Introduction: Hepatitis C virus (HCV) infection is a worldwide public health problem with multisystemic involvements including kidneys. We assessed the prevalence and determinants of kidney markers among HCV infected subjects. Methods: A cross-sectional study was conducted from March to July 2017 in two referral centers in Yaoundé. Sociodemographic, clinical and paraclinical data were collected from patient’s records. Renal involvement was evaluated using estimated glomerular filtration rate (eGFR) by Modification of Diet in Renal Disease’s (MDRD) equation, urine dipstick and albumin/creatinine ratio (ACR). An eGFR < 60 and between 60 - 89 mL/min/1.73 m 2 was defined as low and reduced respectively. Albuminuria was defined by an ACR > 30 mg/g and divided into A1 (<30 mg/g), A2 (30 - 300 mg/g) and A3 (>300 mg/g). Results: We included 65 (41.5% males) HCV infected patients with a mean age of 56.8 ± 10.5 years. HCV infection was diagnosed for more than 5 years in 54 (83.1%) patients. HCV viral load and genotype were available in 40 (61.5%) patients; viral load was high (>5.9 logs/mL) in 20 (50%) of them and genotypes 4 (40%), 1 (32.5%) and 2 (27.5%) were found in this population. The mean eGFR was 112.9 ± 31.9 mL/min/1.73 m 2 with 14 (21.5%) and 4 (6.2%) patients having reduced and low eGFR respectively. Albuminuria (80%), leukocyturia (24.6%) and hematuria (4.6%) were the observed dipstick abnormalities. Median albuminuria (IQR) was 542.4 (238.7 - 961.5) mg/g, with 7 (11%), 12 (18%) and 46 (71%) patients in A1, A2 and A3 respectively. Reduced/low eGFR and albuminuria were observed in 58 (89.2%) patients while low eGFR and albuminuria were found in 55 (84.6%) patients. Advanced age, female gender, HCV genotype 1 and 4, and albuminuria (all p < 0.03) were associated with eGFR reduction. Conclusion: Renal abnormalities are common in HCV infected patients leading by proteinuria and decreased eGFR. Known risk factors of kidney diseases, HCV genotype 1 and 4 and albuminuria were associated with eGFR reduction in our setting.
KeywordsHepatitis C VirusChronic Kidney DiseasePrevalenceSub-Saharan Africa
World Health Organization (2017) Global Hepatitis Programme. Global Hepatitis Report. http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1
Hallager, S., Ladelund, S., Christensen, P.B., Kjær, M., Thorup Roege, B., Grønbæk, K.E., et al. (2017) Liver-Related Morbidity and Mortality in Patients with Chronic Hepatitis C and Cirrhosis with and without Sustained Virologic Response. Clinical Epidemiology, 9, 501-516. https://doi.org/10.2147/CLEP.S132072
Esteban, J.I., Sauleda, S. and Quer, J. (2008) The Changing Epidemiology of Hepatitis C Virus Infection in Europe. Journal of Hepatology, 48, 148-162. https://doi.org/10.1016/j.jhep.2007.07.033
El-Ghitany, E.M. and Farghaly, A.G. (2019) Geospatial Epidemiology of Hepatitis C Infection in Egypt 2017 by Governorate. Heliyon, 5, 1-8. https://doi.org/10.1016/j.heliyon.2019.e02249
Bigna, J.J., Amougou, M.A., Asangbeh, S.L., Kenne, A.M. and Nansseu, J.R. (2017) Seroprevalence of Hepatitis C Virus Infection in Cameroon: A Systematic Review and Meta-Analysis. BMJ Open, 7, e015748. https://doi.org/10.1136/bmjopen-2016-015748
Kowo, M.P., Goubau, P., Ndam, E.C., Njoya, O., Sasaki, S., Seghers, V., et al. (1995) Prevalence of Hepatitis C Virus and Other Blood-Borne Viruses in Pygmies and Neighbouring Bantus in Southern Cameroon. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 484-486. https://doi.org/10.1016/0035-9203(95)90076-4
Maasoumy, B. and Wedemeyer, H. (2012) Natural History of Acute and Chronic Hepatitis C. Best Practice & Research Clinical Gastroenterology, 26, 401-412. https://doi.org/10.1016/j.bpg.2012.09.009
Cacoub, P., Poynard, T., Ghillani, P., Charlotte, F., Olivi, M., Piette, J.C., et al. (1999) Extrahepatic Manifestations of Chronic Hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis & Rheumatology, 42, 2204-2212. https://doi.org/10.1002/1529-0131(199910)42:10 3.0.CO;2-D
Sherman, A.C. and Sherman, K.E. (2015) Extrahepatic Manifestations of Hepatitis C Infection: Navigating CHASM. Current HIV/AIDS Reports, 12, 353-361. https://doi.org/10.1007/s11904-015-0274-8
Cacoub, P., Comarmond, C., Domont, F., Savey, L., Desbois, A.C. and Saadoun, D. (2016) Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection. Therapeutic Advances in Infectious Disease, 3, 3-14. https://doi.org/10.1177/2049936115585942
Cacoub, P., Gragnani, L., Comarmond, C. and Zignego, A.L. (2014) Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection. Digestive and Liver Disease, 46, S165-S173. https://doi.org/10.1016/j.dld.2014.10.005
Tarantino, A., Campise, M., Banfi, G., Confalonieri, R., Bucci, A., Montoli, A., et al. (1995) Long-Term Predictors of Survival in Essential Mixed Cryoglobulinemic Glomerulonephritis. Kidney International, 47, 618-623. https://doi.org/10.1038/ki.1995.78
Levey, A.S., de Jong, P.E., Coresh, J., El Nahas, M., Astor, B.C., Matsushita, K., et al. (2011) The Definition, Classification, and Prognosis of Chronic Kidney Disease: A KDIGO Controversies Conference Report. Kidney International, 80, 17-28. https://doi.org/10.1038/ki.2010.483
Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C Work Group KDIGO (2018) Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney International Supplements, 8, 91-165. https://doi.org/10.1016/j.kisu.2018.06.001
Levey, A.S., Coresh, J., Greene, T., Stevens, L.A. Zhang, Y., Hendriksen, S., et al. (2006) Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate. Annals of Internal Medicine, 145, 247. https://doi.org/10.7326/0003-4819-145-4-200608150-00004
Levey, A.S., Stevens, L.A., Schmid, C.H., Zhang, Y., Castro, A.F., Feldman, H.I., et al. (2009) A New Equation to Estimate Glomerular Filtration Rate. Annals of Internal Medicine, 150, 604. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
Goel, A., Bhadauria, D.S. and Aggarwal, R. (2018) Hepatitis C Virus Infection and Chronic Renal Disease: A Review. Indian Journal of Gastroenterology, 37, 492-503. https://doi.org/10.1007/s12664-018-0920-3
Sabry, A., El-Agroudy, A., Sheashaa, H., El-Husseini, A., Taha, N.M., Elbaz, M., et al. (2005) Histological Characterization of HCV-Associated Glomerulopathy in Egyptian Patients. International Urology and Nephrology, 37, 355-361. https://doi.org/10.1007/s11255-004-4096-7
Naicker, S., Fabian, J., Naidoo, S., Wadee, S., Paget, G. and Goetsch, S. (2007) Infection and Glomerulonephritis. Seminars in Immunopathology, 29, 397-414. https://doi.org/10.1007/s00281-007-0088-x
Mohammed, R.H.A., ElMakhzangy, H.I., Gamal, A., Mekky, F., El Kassas, M., Mohammed, N., et al. (2010) Prevalence of Rheumatologic Manifestations of Chronic Hepatitis C Virus Infection among Egyptians. Clinical Rheumatology, 29, 1373-1380. https://doi.org/10.1007/s10067-010-1463-x
Luma, H.N., Halle, M.P., Fiacre, S.A., Azingala, F., Kamdem, F., Donfack-Sontsa, O., et al. (2017) Seroprevalence of Human Immunodeficiency Virus, Hepatitis B and C Viruses among Haemodialysis Patients in Two Newly Opened Centres in Cameroon. Pan African Medical Journal, 27, 1-10. https://doi.org/10.11604/pamj.2017.27.235.13121
Poynard, T., Bedossa, P. and Opolon, P. (1997) Natural History of Liver Fibrosis Progression in Patients with Chronic Hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC Groups. The Lancet (London, England), 349, 825-832. https://doi.org/10.1016/S0140-6736(96)07642-8
European Association for the Study of the Liver (2011) EASL Clinical Practice Guidelines: Management of Hepatitis C Virus Infection. Journal of Hepatology, 55, 245-264. https://doi.org/10.1016/j.jhep.2011.02.023
Meffre, C., Le Strat, Y., Delarocque-Astagneau, E., Dubois, F., Antona, D., Lemasson, J.-M., et al. (2010) Prevalence of Hepatitis B and Hepatitis C Virus Infections in France in 2004: Social Factors Are Important Predictors after Adjusting for Known Risk Factors. Journal of Medical Virology, 82, 546-555. https://doi.org/10.1002/jmv.21734
Desenclos, J.C. (2000) Epidemiology of Hepatitis C. La Revue du Praticien, 50, 1066-1070.
Denniston, M.M., Jiles, R.B., Drobeniuc, J., Klevens, R.M., Ward, J.W., McQuillan, G.M., et al. (2014) Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Annals of Internal Medicine, 160, 293-300. https://doi.org/10.7326/M13-1133
Tsui, J.I., Vittinghoff, E., Shlipak, M.G. and O’Hare, A.M. (2006) Relationship between Hepatitis C and Chronic Kidney Disease: Results from the Third National Health and Nutrition Examination Survey. Journal of the American Society of Nephrology: JASN, 17, 1168-1174. https://doi.org/10.1681/ASN.2005091006
Naga, M. (2015) Low-Density Lipoprotein Receptor Genetic Polymorphism in Chronic Hepatitis C Virus Egyptian Patients Affects Treatment Response. World Journal of Gastroenterology, 21, 11141-11151. https://doi.org/10.3748/wjg.v21.i39.11141
Liangpunsakul, S. and Chalasani, N. (2005) Relationship between Hepatitis C and Microalbuminuria: Results from the NHANES III. Kidney International, 67, 285-290. https://doi.org/10.1111/j.1523-1755.2005.00080.x
Akiyama, T., Mizuta, T., Kawazoe, S., Eguchi, Y., Kawaguchi, Y., Takahashi, H., et al. (2011) Body Mass Index Is Associated with Age-at-Onset of HCV-Infected Hepatocellular Carcinoma Patients. World Journal of Gastroenterology, 17, 914-921. https://doi.org/10.3748/wjg.v17.i7.914
Karoney, M.J. and Siika, A.M. (2013) Hepatitis C Virus (HCV) Infection in Africa: A Review. Pan African Medical Journal, 14, 44. https://doi.org/10.11604/pamj.2013.14.44.2199
Sonderup, M.W., Afihene, M., Ally, R., Apica, B., Awuku, Y., Cunha, L., et al. (2017) Hepatitis C in Sub-Saharan Africa: The Current Status and Recommendations for Achieving Elimination by 2030. The Lancet Gastroenterology and Hepatology, 2, 910-919. https://doi.org/10.1016/S2468-1253(17)30249-2
Njouom, R., Frost, E., Deslandes, S., Mamadou-Yaya, F., Labbé, A.-C., Pouillot, R., et al. (2009) Predominance of Hepatitis C Virus Genotype 4 Infection and Rapid Transmission between 1935 and 1965 in the Central African Republic. Journal of General Virology, 90, 2452-2456. https://doi.org/10.1099/vir.0.011981-0
Ndong-Atome, G.R., Makuwa, M., Ouwe-Missi-Oukem-Boyer, O., Pybus, O.G., Branger, M., Le Hello, S., et al. (2008) High Prevalence of Hepatitis C Virus Infection and Predominance of Genotype 4 in Rural Gabon. Journal of Medical Virology, 80, 1581-1587. https://doi.org/10.1002/jmv.21252
Saddadi, F., Attari, F., Najafi, I., Gangi, M.R., Hakemi, M. and Amini, M. (2010) Renal Involvement in Patients with Hepatitis C Virus Infection. The Iranian Journal of Kidney Diseases, 4, 123-127.
Huang, J.-F., Chuang, W.-L., Dai, C.-Y., Ho, C.-K., Hwang, S.-J., Chen, S.-C., et al. (2006) Viral Hepatitis and Proteinuria in an Area Endemic for Hepatitis B and C Infections: Another Chain of Link? Journal of Internal Medicine, 260, 255-262. https://doi.org/10.1111/j.1365-2796.2006.01686.x
Ozkok, A. and Yildiz, A. (2014) Hepatitis C Virus Associated Glomerulopathies. World Journal of Gastroenterology, 20, 7544-7554. https://doi.org/10.3748/wjg.v20.i24.7544
Perico, N., Cattaneo, D., Bikbov, B. and Remuzzi, G. (2009) Hepatitis C Infection and Chronic Renal Diseases. Clinical Journal of the American Society of Nephrology, 4, 207-220. https://doi.org/10.2215/CJN.03710708
Sansonno, D., Lauletta, G., Montrone, M., Grandaliano, G., Schena, F.P. and Dammacco, F. (2005) Hepatitis C Virus RNA and Core Protein in Kidney Glomerular and Tubular Structures Isolated with Laser Capture Microdissection. Clinical & Experimental Immunology, 140, 498-506. https://doi.org/10.1111/j.1365-2249.2005.02778.x
Iseki, K., Ikemiya, Y., Iseki, C. and Takishita, S. (2003) Proteinuria and the Risk of Developing End-Stage Renal Disease. Kidney International, 63, 1468-1474. https://doi.org/10.1046/j.1523-1755.2003.00868.x
Association Médicale Mondiale (2013) Déclaration d’Helsinki de l’Association Médicale Mondiale: Principes éthiques applicables aux recherches médicales sur des sujets humains. https://www.wma.net/fr/policies-post/declaration-dhelsinki-de-lamm-principes-ethiques-applicables-a-la-recherche-medicale-impliquant-des-etres-humains
World Health Organization, Council for International Organizations of Medical Sciences (2017) International Ethical Guidelines for Health-Related Research Involving Humans. CIOMS, Geneva.